.png)
Agenzia Italiana del Farmaco
home
Highlights
-
04 Jun 2025
Press releases
AIFA launches the 2025 Independent Research Call on rare diseases
For the promotion of studies on low-prevalence diseases, which often do not attract significant commercial investment.
-
16 May 2025
Press releases
Eugenia Cogliandro elected Chair of the European Pharmacopoeia Commission
She will take up her duties during the 182nd session of the EPC on 17 June 2025, for a three-year term.
-
14 May 2025
Press releases
AIFA Board Approves Reimbursement of 11 Drugs
The new medicinal products that will be eligible for reimbursement are: 1 orphan medicinal product, 4 new medicinal products, 2 generic medicines, 1 parallel import medicinal product and 3 extensions of therapeutic indications.
-
30 Apr 2025
Press releases
Pharmaceutical expenditure for direct purchases by the Regions slows in the last months of the year but it exceeds the 2024 ‘ceiling’ by 3.6 billion
Considering that several medicines shifted from the innovative fund to the direct purchases one, the trend is in line with previous years. For the NHS approved care regime there was a surplus of 651 million.
News
06 Jun 2025
Safety of medicinal products
Important update from the PRAC about Ozempic, Rybelsus and Wegovy (semaglutide)
06 Jun 2025
Safety of medicinal products
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) - 2-5 june 2025
06 Jun 2025
Information and communication
Reducing the environmental impact of medicinal products: some activities proposed by European expert working group
05 Jun 2025
Innovative medicinal products
List of innovative drugs by single indication (2024)
30 May 2025
Clinical trials concerning medicinal products
Map of Clinical Trial Sites
29 May 2025
Safety of medicinal products
Direct communication with healthcare professionals on Mysimba (naltrexone/bupropione)
FarmaciLine
Questions regarding drug efficacy, safety and availability
TOLL-FREE NUMBER
Services
Interactive OsMed - The use of medicines in Italy
An interactive consultation of data on the use of medicines in Italy in the general and regional population, described in terms of expenditure, volumes, typology
